| Sep 10 |
Vir Biotechnology closes Sanofi licence deal for T-cell engagers
|
| Sep 6 |
Why Is Kymera Therapeutics (KYMR) Up 10.9% Since Last Earnings Report?
|
| Sep 6 |
Men taking valproate and their partners warned to use contraception by MHRA
|
| Sep 6 |
Pharma Stock Roundup: EU Nod for Expanded Use of MRK's Keytruda & More
|
| Sep 4 |
UK regulators find no link between certain GLP-1 drugs, suicidal thoughts
|
| Sep 3 |
Why Sanofi Stock Was Robustly Healthy Today
|
| Sep 3 |
Sanofi: A Long-Term Cash Cow With High Dividends
|
| Sep 3 |
Sanofi Still Bets On Multiple Sclerosis Med Tolebrutinib Despite The Investigational Drug Fell Short In 2 Of 3 Phase 3 Trials
|
| Sep 3 |
Sanofi finds a silver lining in mixed MS drug results
|
| Sep 2 |
SNY's MS Drug Meets Goal in One Phase III Study; Misses in Two Others
|
